AI Summary
Molnupiravir, an antiviral drug for COVID-19, causes mutations in the SARS-CoV-2 genome, potentially leading to the creation of new viral variants.
NEWS AND VIEWS 24 October 2023
Molnupiravir, an antiviral drug used to treat COVID-19, induces numerous mutations in the SARS-CoV-2 genome that can increase the rate at which the virus evolves — yielding viral variants that might survive and be passed on.